DEFICIENT FE59 AND I125-DEOXYURIDINE UPTAKE BY LYMPHO-HEMOPOIETIC CELL TRANSPLANTS ENGAGED IN HOMOGRAFT REACTIONS,

Abstract

Erythropoietic activity of spleen cell grafts was measured (Fe59 uptake) in X-irradiated recipient mice under conditions in which these grafts were engaged in homograft reactions against allogeneic target cells or in graft-versus-host reactions. Such Fe59 incorporation was greatly reduced at 7 to 10 days after graft implantation relative to that of control grafts. This reduced erythropoiesis did not occur when the spleen cell graft was immunologically incompetent. Transplantation of bone marrow-lymph node cell mixtures also resulted in a relative decline in Fe59 uptake, but only when minimal numbers of marrow cells were injected. The incorporation of I 125 UdR in the spleen of irradiated recipients was used to assess cellular proliferation. Incorporation of this label was reduced when measured 7 - 10 days after implantation of the lympho-hemopoietic cell graft, but reached a peak at 5 days--the latter indicating stimulated lymphopoiesis. These data are consistent with the concept of depletion of a pluripotent stem cell pool (limited in size under these experimental conditions) due to excessive and concurrent functional demands for erythropoiesis and lymphopoiesis. An alternative explanation would involve cytotoxic effects on hemopoietic elements present in the milieu of the immunologic reaction. (Author)

Document Details

Document Type
Technical Report
Publication Date
Feb 27, 1968
Accession Number
AD0665684

Entities

People

  • Leonard J. Cole
  • Raymond Schofield
  • William E. Davis Jr.

Organizations

  • Naval Radiological Defense Laboratory

Tags

DTIC Thesaurus Topics

  • Allografts
  • Bone Marrow
  • Bones
  • Cells
  • Erythropoiesis
  • Implantation
  • Lymph Nodes
  • Lymphatic System
  • Stem Cells
  • Transplantation
  • Transplants

Fields of Study

  • Biology
  • Medicine

Readers

  • Immunology
  • Systems Analysis and Design

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech